Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Zejula, Revatio Advisory Committee Meetings Cancelled; Palovarotene Panel Postponed
Oct 26 2022
•
By
Brenda Sandburg
FDA cancels two advisory committee meetings, including 22 November consideration of Zejula sNDA, and postpones another • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from US FDA Performance Tracker
More from Regulatory Trackers